- Globus Maritime (GLBS) +109%.
- Axovant Sciences (AXGT) +45% on clinical update from first Tay-Sachs disease patient dosed with AXO-AAV-GM2 gene therapy.
- Pyxis Tankers (PXS) +43%.
- Tonix Pharmaceuticals Holding (TNXP) +28% as first participant was enrolled in the RECOVERY study, a new Phase 3 study of Tonmya.
- PolarityTE (PTE) +26% ahead of its corporate presentation.
- Cellect Biotechnology (APOP) +19% on positive results from Cell2in collaboration.
- DropCar (DCAR) +18%.
- Inpixon (INPX) +13% on receiving a Notice of Allowance from the U.S. Patent and Trademark Office allowing its patent application covering techniques to expedite joins of large database tables.
- ToughBuilt (TBLT) +12% on announcing that USPTO has granted two new design patents that cover ToughBuilt's ruggedized mobile devices, which are valid for a period of 15 years.
- SenesTech (SNES) +12% as ContraPest has completed initial trials in hosted poultry farms and will begin first commercial application in egg production facilities in California's central valley.
- TrovaGene (TROV) +11%.
- Bio-Path Holdings (BPTH) +9%.
- Mellanox Technologies (MLNX) +9% on being acquired by Nvidia.
- USA Technologies (USAT) +9%.
- China Internet Nationwide Financial Services (CIFS) +8%.
- Safe-T Group (SFET) +8%.
- Bristow Group (BRS) +6%.
- CHF Solutions (CHFS) +6%.